11
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Non-Steroidal Anti-Inflammatory Drugs and the Chemoprevention of Gastrointestinal Cancers

Pages 785-789 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

. (2001) Cyclooxygenase-2 in Carcinogenesis of the Gastrointestinal Tract. Scandinavian Journal of Gastroenterology 36:9, pages 897-903.
Read now

Articles from other publishers (8)

Madhumita Das, Upashi Goswami, Srirupa Bhattacharyya, Raghuram Kandimalla, Arun Chattopadhyay & Siddhartha Sankar Ghosh. (2019) Integration of a Nonsteroidal Anti-Inflammatory Drug with Luminescent Copper for in Vivo Cancer Therapy in a Mouse Model . ACS Applied Bio Materials 3:1, pages 227-238.
Crossref
Lei Duan, Anna H. Wu, Jane Sullivan-Halley & Leslie Bernstein. (2008) Nonsteroidal Anti-inflammatory Drugs and Risk of Esophageal and Gastric Adenocarcinomas in Los Angeles County. Cancer Epidemiology, Biomarkers & Prevention 17:1, pages 126-134.
Crossref
A. Goel, C. Gasche & C. R. Boland. 2008. Intestinal Inflammation and Colorectal Cancer. Intestinal Inflammation and Colorectal Cancer 244 253 .
E.G. Giannini, S.V. Kane, R. Testa & V. Savarino. (2005) 5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: Can we afford to wait for ‘best evidence’?. Digestive and Liver Disease 37:10, pages 723-731.
Crossref
H. Allgayer. (2003) Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 18:s2, pages 10-14.
Crossref
F.A. Wenger, M. Kilian, P. Achucarro, D. Heinickena, I. Schimke, H. Guski, C.A. Jacobi & J.M. Müller. (2002) Effects of Celebrex and Zyflo on BOP-induced pancreatic cancer in syrian hamsters. Pancreatology 2:1, pages 54-60.
Crossref
Theresa Mays-Holland. (2017) Chemoprevention of Colorectal Cancer. Hospital Pharmacy 35:9, pages 964-979.
Crossref
S. J. Walker, J. P. Byrne & N. Birbeck. (1999) What’s new in the pathology, pathophysiology and management of benign esophageal disorders?. Diseases of the Esophagus 12:3, pages 219-237.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.